Europe Humanized Mice Model Market By Type (Genetic Humanized Mice Model v/s Cell-Based Humanized Mice Model), By Application (Oncology, Immunology & Infectious Diseases, Neuroscience, Toxicology, Others), By End-use (Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, Contract Research Organizations), By Country, Competition, Forecast & Opportunities, 2028
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationEurope Humanized Mice Model Market By Type (Genetic Humanized Mice Model v/s Cell-Based Humanized Mice Model), By Application (Oncology, Immunology & Infectious Diseases, Neuroscience, Toxicology, Others), By End-use (Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, Contract Research Organizations), By Country, Competition, Forecast & Opportunities, 2028
Europe humanized mice model market is expected to witness significant growth during the forecast period 2024-2028. Increasing prevalence of cancer along with the rise in number of research & development activities in pharmaceutical and biotechnology companies are anticipated to facilitate the growth of the market. Moreover, ongoing developments in biological research due to continuous support & initiatives from the governments as well as private sectors are likely to propel the market’s growth. In addition to this, growing demand for personalised medicine are expected to further contribute to market growth. Advances in metabolomics, proteomics, and genomics in the region is creating lucrative growth opportunities in the market. There is a rise in use of humanized mice models in biomedical research including human hematopoiesis, regenerative medicines, transplantation, autoimmunity, and infectious diseases, which is surging the demand for humanised mice model. Moreover, rising government investments and grants plays a key role in strengthening the growth of the market.
Growing demand for Personalised Medicine
For instance, in 2022, Germany had the highest gross expenditure on research and development (GERD) among European countries, which was 143.1 billion U.S. dollars, followed by France at USD 68.5 billion and then UK at USD 54.9 billion.
Growing Occurrences of Various Diseases
. According to the Global Cancer Observatory, in 2020, there were 47,86,818 number of new cases, out of which 5,76,337 cases were of breast cancer, 5,54,569 cases were of colorectum, 5,34,496 cases were of lung, 5,00,827 cases were of prostate, 2,21,298 cases were of bladder, and 2,399,291 cases of other cancers.
Recent Developments
- In 2020, The Jackson Laboratoryannounced the availability of hACE2 transgenic mouse model for coronavirusresearch. The strategic move assisted the organization in expanding theircustomer base.
- In 2019, Taconic Biosciences launcheda genetically engineered mice named TRUBIOME.
Market Segmentation
Europe humanized mice model market is segmented into type, application, end user, company, and region. Based on type, the market can be categorized into genetic humanized mice model and cell-based humanized mice model. Cell-based humanized mice model is further classified into CD34 humanized mouse models, PBMC humanized mouse models, and BLT humanized mouse models. Based on application, the market is bifurcated into oncology, immunology & infectious diseases, neuroscience, toxicology, and others. Based on end user, the market is divided into pharmaceutical & biotechnology companies, academic & research institutions, contract research organizations. In terms of countries, the market is divided into Germany, France, United Kingdom, Italy, Spain, Switzerland, Netherland, Poland, Sweden, and Belgium.
Market Players
Charles River Laboratories, International, Inc., The Jackson Laboratory, Gempharmatech Co Ltd, Taconic Biosciences, Inc., Envigo (Harlan Laboratories, Inc.), Laboratory Corporation of America Holdings, Janvier Labs, Trans Genic, Inc., genOway, and Creative Biolabd are some of the leading companies in the market.
| Attribute | Details |
| Base Year | 2022 |
| Historic Data | 2018 – 2021 |
| Estimated Year | 2023 |
| Forecast Period | 2024 – 2028 |
| Quantitative Units | Revenue in USD Million and CAGR for 2018-2022 and 2023-2028 |
| Report coverage | Revenue forecastvolume forecast, company share, competitive landscape, growth factors, and trends |
| Segments covered | Type Application End User Country |
| Country scope | Germany, France, United Kingdom, Italy, Spain, Switzerland, Netherland, Poland, Sweden, Belgium |
| Key companies profiled | Charles River Laboratories, International, Inc., The Jackson Laboratory, Gempharmatech Co Ltd, Taconic Biosciences, Inc., Envigo (Harlan Laboratories, Inc.), Laboratory Corporation of America Holdings, Janvier Labs, Trans Genic, Inc., Genoway, Creative Biolabd |
| Customization scope | 10% free report customization with purchase. Addition or alteration to country, & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy